Ali H. Shakir, M.D., Richard W. Smalling, M.D., Ph.D., and Rebecca R. Hung, M.D.
Dr. Shakir is a Fellow, and Dr. Hung is Assistant Professor and Associate Director of Heart Failure, Division of Cardiovascular Medicine, University of Texas Health Science Center, Houston, Texas.
Dr. Shakir reports no commercial conflict of interest. Dr. Hung has been a consultant to Scios and GSK and Dr. Smalling has received grant/research support from Centocor/Boston Scientific within the last three years.
This activity is made possible by an unrestricted educational grant from Roche Diagnostics
.
Release Date: 12/01/2003
Upon completion of this Cyberounds®, you should be able to:
List the physiologic properties of B-type natriuretic peptide (BNP) and NT-proBNP
Describe the utility and limitations of measuring plasma BNP and NT-proBNP levels in the diagnosis and management of congestive heart failure
Discuss the role of recombinant BNP (nesiritide) in the treatment of decompensated heart failure.